Bullshit. I don't care what AI says. You are looking at $200-300 million for a properly run ( joke for Missling) 1,000+ person trial. They don't have the $$$ and who the heck (sub in F) would want to invest in them? Who would buy shares as dilution essential. Why not look into ANNX for unique needs vs everyone going for the holy grail of ALZ. Doubled since I first suggested it here.
Market Data 
Markets 
